We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 383 results
  1. Hereditary TTP/Upshaw–Schulman syndrome: the ductus arteriosus controls newborn survival

    Hereditary TTP (hTTP), termed Upshaw–Schulman syndrome, is an ultra-rare disorder caused by a severe deficiency of plasma ADAMTS13 activity that...

    Yoshihiro Fujimura in International Journal of Hematology
    Article 27 March 2024
  2. Regulation of von Willebrand factor by ADAMTS13 ameliorates lipopolysaccharide-induced lung injury in mice

    The relationship between von Willebrand factor (VWF) and inflammation has attracted considerable attention in recent years. VWF, which is stored in...

    Yu Onodera, Seiji Mitani, ... Kohei Tatsumi in International Journal of Hematology
    Article 27 September 2023
  3. Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow

    Background

    Von Willebrand factor (VWF) and factor VIII (FVIII) complex play a pivotal role in hemostasis. A deficiency or defect of VWF causes von...

    Hiroaki Yaoi, Yasuaki Shida, ... Keiji Nogami in Thrombosis Journal
    Article Open access 08 December 2023
  4. Impact of rise and fall phases of shear on platelet activation and aggregation using microfluidics

    Blood flow disorders are often the result of the non-physiological narrowing of blood arteries caused by atherosclerosis and thrombus. The blood then...

    Xuemei Gao, Tiancong Zhang, ... Yuan Li in Journal of Thrombosis and Thrombolysis
    Article 31 March 2024
  5. ADAMTS13 in pediatric sepsis: a prognostic biomarker with potential therapeutic implications

    Background

    Growing evidence implicates a pro-thrombotic state, caused by ADAMTS13 deficiency, in sepsis-associated organ dysfunction, but pediatric...

    Muhammad Said El-Mekkawy, Sara Mahmoud El-Deeb, Maha Fawzy El-Hanafy in Egyptian Pediatric Association Gazette
    Article Open access 20 December 2023
  6. Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura

    Thrombotic thrombocytopenic purpura (TTP) is a fatal disease in which platelet-rich microthrombi cause end-organ ischemia and damage. TTP is caused...

    Masayuki Kubo, Masanori Matsumoto in International Journal of Hematology
    Article 09 February 2023
  7. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023

    Thrombotic thrombocytopenic purpura (TTP) can rapidly become a life-threatening condition, and the importance of its appropriate diagnosis and...

    Masanori Matsumoto, Yoshitaka Miyakawa, ... Yoshihiro Fujimura in International Journal of Hematology
    Article Open access 10 September 2023
  8. VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis

    Aim

    We investigated the von Willebrand factor to ADAMTS13 ratio (von Willebrand factor [VWF]:Ag/ADAMTS13:AC) as a potential biomarker for the outcomes...

    Shohei Asada, Tadashi Namisaki, ... Hitoshi Yoshiji in Digestive Diseases and Sciences
    Article 20 January 2024
  9. COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm

    ADAMTS13, a metalloproteinase, specifically cleaves unusually large multimers of von Willebrand factor (VWF), newly released from vascular...

    Yoshihiro Fujimura, Linda Z. Holland in International Journal of Hematology
    Article 22 March 2022
  10. Exosomes from bone marrow mesenchymal stem cells ameliorate glucocorticoid-induced osteonecrosis of femoral head by transferring microRNA-210 into bone microvascular endothelial cells

    Objectives

    Bone microvascular endothelial cells (BMECs) played an important role in the pathogenesis of glucocorticoid-induced osteonecrosis of...

    Che Zheng, Yuangang Wu, ... Jun Ma in Journal of Orthopaedic Surgery and Research
    Article Open access 07 December 2023
  11. Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement

    The coagulation, fibrinolytic, anticoagulation, and complement systems are in delicate balance with the vessel wall endothelium ensuring appropriate...

    Mohammad Sayyadi, Saeed Hassani, ... Akbar Dorgalaleh in Annals of Hematology
    Article 19 April 2023
  12. The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study

    Background

    Extracorporeal membrane oxygenation (ECMO) is applied in patients with respiratory or cardiopulmonary failure, but bleeding is a frequent...

    Martin Büchsel, Ulrich Geisen, ... Patrick M. Siegel in Thrombosis Journal
    Article Open access 10 January 2023
  13. Reversible skin microvascular hyporeactivity in patients with immune-mediated thrombocytopenic thrombotic purpura

    Background

    Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare disease characterized by arteriolar and capillary microthrombosis...

    Jérémie Joffre, Lisa Raia, ... Hafid Ait-Oufella in Critical Care
    Article Open access 21 March 2023
  14. Tissue factor regulates autophagy in pulmonary artery endothelial cells from chronic thromboembolic pulmonary hypertension rats via the p38 MAPK-FoxO1 pathway

    Aims

    To detect the expression of autophagy components, p38 MAPK (p38) and phosphorylated forkhead box transcription factor O-1 (pFoxO1) in pulmonary...

    Dawen Wu, Yi Lin, ... Chaosheng Deng in Respiratory Research
    Article Open access 28 June 2024
  15. Anasarca and spontaneous intramuscular haemmorhage in a dermatomyositis patient: case report and review of the literature

    Dermatomyositis is a rare, autoimmune systemic disorder of unknown aetiology that presents as a constellation of clinical symptoms and signs...

    Ioannis Xynogalas, Polychroniadis Michail, ... Anastasios Karamanakos in Clinical Rheumatology
    Article 11 June 2024
  16. Wenyang Huazhuo Tongluo formula alleviates pulmonary vascular injury and downregulates HIF-1α in bleomycin-induced systemic sclerosis mouse model

    Background

    Vascular damage, autoimmune abnormalities, and fibrosis are the three pathological features of systemic sclerosis (SSc).However, pulmonary...

    Kai Li, Qian Wang, ... Hua Bian in BMC Complementary Medicine and Therapies
    Article Open access 22 June 2022
  17. Coagulation Management in End-Stage Liver Disease

    Purpose of Review

    There is a precarious and altered balance in the hemostatic function encountered in patients with end-stage liver disease (ESLD)....

    Shashank S. Shettar, Kofi Vandyck, Kenichi A. Tanaka in Current Anesthesiology Reports
    Article 20 April 2022
  18. COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles

    COVID-19, caused by the SARS-CoV-2 virus, is responsible for a pandemic of unparalleled portion over the past century. While the acute phase of...

    Richard C. Becker, Travis Sexton, Susan Smyth in Journal of Thrombosis and Thrombolysis
    Article 04 August 2021
Did you find what you were looking for? Share feedback.